Literature DB >> 33481924

Predictors of death after receiving a modified Blalock-Taussig shunt in cyanotic heart children: A competing risk analysis.

Maliwan Oofuvong1, Jutarat Tanasansuttiporn1, Wirat Wasinwong1, Voravit Chittithavorn2, Pongsanae Duangpakdee2, Jirayut Jarutach3, Qistina Yunuswangsa1.   

Abstract

OBJECTIVE: To determine risk factors affecting time-to-death ≤90 and >90 days in children who underwent a modified Blalock-Taussig shunt (MBTS).
METHODS: Data from a retrospective cohort study were obtained from children aged 0-3 years who experienced MBTS between 2005 and 2016. Time-to-death (prior to Glenn/repair), time-to-alive up until December 2017 without repair, and time-to-progression to Glenn/repair following MBTS were presented using competing risks survival analysis. Demographic, surgical and anesthesia-related factors were recorded. Time-to-death ≤90 days and >90 days was analyzed using multivariate time-dependent Cox regression models to identify independent predictors and presented by adjusted hazard ratios (HR) and 95% confidence intervals (CI).
RESULTS: Of 380 children, 119 died, 122 survived and 139 progressed to Glenn/repair. Time-to-death probability (95% CI) within 90 days was 0.18 (0.14-0.22). Predictors of time-to-death ≤90 days (n = 63) were low weight (<3 kg) (HR 7.6, 95% CI:2.8-20.4), preoperative ventilator support (HR 2.7, 95% CI:1.3-5.6), postoperative shunt thrombosis (HR 5.0, 95% CI:2.4-10.4), bleeding (HR 4.5, 95% CI:2.1-9.4) and renal failure (HR 4.1, 95% CI:1.5-10.9). Predictors of time-to-death >90 days (n = 56) were children diagnosed with pulmonary atresia with ventricular septal defect and single ventricle (compared to tetralogy of fallot) (HR 3.2, 95% CI:1.2-7.7 and HR 3.1, 95% CI:1.3-7.6, respectively), shunt size/weight ratio >1.1 vs <0.65 (HR 6.8, 95% CI:1.4-32.6) and longer duration of mechanical ventilator (HR 1.002, 95% CI:1.001-1.004). Shunt size/weight ratio ≥1.0 (vs <1.0) and ≥0.65 (vs <0.65) were predictors for overall time-to-death in neonates and toddlers, respectively (HR 13.1, 95% CI:2.8-61.4 and HR 7.8, 95% CI:1.7-34.8, respectively).
CONCLUSIONS: Perioperative factors were associated with time-to-death ≤90 days, whereas particular cardiac defect, larger shunt size/weight ratio, and longer mechanical ventilation were associated with time-to-death >90 days after receiving MBTS. Larger shunt size/weight ratio should be reevaluated within 90 days to minimize the risk of shunt over flow.

Entities:  

Mesh:

Year:  2021        PMID: 33481924      PMCID: PMC7822344          DOI: 10.1371/journal.pone.0245754

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  30 in total

1.  Pulmonary atresia/intact ventricular septum: influence of coronary anatomy on single-ventricle outcome.

Authors:  Eva W Cheung; Marc E Richmond; Mariel E Turner; Emile A Bacha; Alejandro J Torres
Journal:  Ann Thorac Surg       Date:  2014-08-22       Impact factor: 4.330

2.  Risk factors for acute shunt blockage in children after modified Blalock-Taussig shunt operations.

Authors:  Malenke Gedicke; Gareth Morgan; Andrew Parry; Rob Martin; Rob Tulloh
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

3.  Risk factors for mortality and morbidity after the neonatal Blalock-Taussig shunt procedure.

Authors:  Orlando Petrucci; Sean M O'Brien; Marshall L Jacobs; Jeffrey P Jacobs; Peter B Manning; Pirooz Eghtesady
Journal:  Ann Thorac Surg       Date:  2011-05-08       Impact factor: 4.330

4.  Impact of neonatal versus nonneonatal total repair of tetralogy of fallot on growth in the first year of life.

Authors:  Kristal L Woldu; Bhawna Arya; Emile A Bacha; Ismée A Williams
Journal:  Ann Thorac Surg       Date:  2014-08-15       Impact factor: 4.330

5.  Interim mortality in pulmonary atresia with intact ventricular septum.

Authors:  Kathleen N Fenton; Frank A Pigula; Sanjiv K Gandhi; Linda Russo; Kim F Duncan
Journal:  Ann Thorac Surg       Date:  2004-12       Impact factor: 4.330

6.  Outcomes in neonatal pulmonary atresia with intact ventricular septum. A multiinstitutional study.

Authors:  F L Hanley; R M Sade; E H Blackstone; J W Kirklin; R M Freedom; N C Nanda
Journal:  J Thorac Cardiovasc Surg       Date:  1993-03       Impact factor: 5.209

7.  Two thousand Blalock-Taussig shunts: a six-decade experience.

Authors:  Jason A Williams; Anshuman K Bansal; Bradford J Kim; Lois U Nwakanma; Nishant D Patel; Akhil K Seth; Diane E Alejo; Vincent L Gott; Luca A Vricella; William A Baumgartner; Duke E Cameron
Journal:  Ann Thorac Surg       Date:  2007-12       Impact factor: 4.330

8.  Management of ventricular septal defect with pulmonary atresia and major aorto pulmonary collateral arteries: Challenges and controversies.

Authors:  Ks Murthy; K Pramod Reddy; R Nagarajan; V Goutami; Km Cherian
Journal:  Ann Pediatr Cardiol       Date:  2010-07

9.  Evaluation of Complications of Heart Surgery in Children With Congenital Heart Disease at Dena Hospital of Shiraz.

Authors:  Maryam Mirzaei; Samaneh Mirzaei; Elham Sepahvand; Afifeh Rahmanian Koshkaki; Marzieh Kargar Jahromi
Journal:  Glob J Health Sci       Date:  2015-08-23

10.  Current era outcomes of pulmonary atresia with ventricular septal defect: A single center cohort in Thailand.

Authors:  Kanthalas Lertsakulpiriya; Chodchanok Vijarnsorn; Prakul Chanthong; Paweena Chungsomprasong; Supaluck Kanjanauthai; Kritvikrom Durongpisitkul; Jarupim Soongswang; Thaworn Subtaweesin; Somchai Sriyoschati
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.